Evidence map›Paper›PMID 37488355›Full record

ArticleNature structural & molecular biology2023

A genome-wide screen reveals new regulators of the 2-cell-like cell state.

Nikhil Gupta, Lounis Yakhou, Julien Richard Albert, Anaelle Azogui, Laure Ferry, Olivier Kirsh, Fumihito Miura, Sarah Battault, Kosuke Yamaguchi, Marthe Laisné and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature structural & molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 3 countries.

Nikhil Gupta *Epigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France. nikhil.gupta@cancer.org.uk.ORCID http://orcid.org/0000-0002-5605-0459
Lounis Yakhou *Epigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.ORCID http://orcid.org/0000-0003-4907-3780
Julien Richard AlbertInstitut Jacques Monod, Université Paris Cité, CNRS, Paris, France.ORCID http://orcid.org/0000-0001-9950-9461
Anaelle AzoguiEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.
Laure FerryEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.
Olivier KirshEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.
Fumihito MiuraDepartment of Biochemistry, Kyushu University Graduate School of Medical Sciences, Fukuoka, Fukuoka, Japan.ORCID http://orcid.org/0000-0003-2656-486X
Sarah BattaultEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.
Kosuke YamaguchiEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.
Marthe LaisnéEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.
Cécilia DomraneEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.
Frédéric BonhommeEpigenetic Chemical Biology, UMR3523, Institut Pasteur, Université Paris Cité, CNRS, Paris, France.
Arpita SarkarIRCAN, Université Côte d'Azur, Inserm, CNRS, Nice, France.
Marine DelagrangeHigh Throughput qPCR Facility, Institut de Biologie de l'École Normale Supérieure (IBENS), Laboratoire de Physique de l'ENS CNRS UMR8023, PSL Research University, Paris, France.
Bertrand DucosHigh Throughput qPCR Facility, Institut de Biologie de l'École Normale Supérieure (IBENS), Laboratoire de Physique de l'ENS CNRS UMR8023, PSL Research University, Paris, France.
Gael CristofariIRCAN, Université Côte d'Azur, Inserm, CNRS, Nice, France.ORCID http://orcid.org/0000-0001-5620-3091
Takashi ItoDepartment of Biochemistry, Kyushu University Graduate School of Medical Sciences, Fukuoka, Fukuoka, Japan.ORCID http://orcid.org/0000-0001-6097-2803
Maxim V C GreenbergInstitut Jacques Monod, Université Paris Cité, CNRS, Paris, France.ORCID http://orcid.org/0000-0001-9935-8763
Pierre-Antoine DefossezEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France. pierre-antoine.defossez@u-paris.fr.ORCID http://orcid.org/0000-0002-6463-9263
Centre National de la Recherche Scientifique · FRKyushu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In mammals, only the zygote and blastomeres of the early embryo are totipotent. This totipotency is mirrored in vitro by mouse '2-cell-like cells' (2CLCs), which appear at low frequency in cultures of embryonic stem cells (ESCs). Because totipotency is not completely understood, we carried out a genome-wide CRISPR knockout screen in mouse ESCs, searching for mutants that reactivate the expression of Dazl, a gene expressed in 2CLCs. Here we report the identification of four mutants that reactivate Dazl and a broader 2-cell-like signature: the E3 ubiquitin ligase adaptor SPOP, the Zinc-Finger transcription factor ZBTB14, MCM3AP, a component of the RNA processing complex TREX-2, and the lysine demethylase KDM5C. All four factors function upstream of DPPA2 and DUX, but not via p53. In addition, SPOP binds DPPA2, and KDM5C interacts with ncPRC1.6 and inhibits 2CLC gene expression in a catalytic-independent manner. These results extend our knowledge of totipotency, a key phase of organismal life.

Indexed as

Transcription FactorsZygoteAnimalsEmbryonic Stem CellsGenomeMammalsMiceMouse Embryonic Stem CellsTranscription Factors

Identifiers

PMID37488355
OpenAlexW4385210175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.